ED50 and ED95 of oxycodone combined with propofol for inhibiting spontaneous movement in patients undergoing hysteroscopic dilatation of cervical canal

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800020007

Enrollment

Unknown

Registered

2018-12-11

Start date

2018-12-13

Completion date

Unknown

Last updated

2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine space occupying

Interventions

1:Oxycotone 0.07mg/Kg, and propofol 1.8mg/Kg

2:Oxycotone 0.07mg/Kg, and propofol 2.0mg/Kg

3:Oxycotone 0.07mg/Kg, and propofol 2.2mg/Kg

4:Oxycotone 0.07mg/Kg, and propofol 2.4mg/Kg

5:Oxycotone 0.07mg/Kg, and propofol 2.6mg/Kg

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Aged 18-40 years, ASA I-II, BMI 18-30

Exclusion criteria

Exclusion criteria: Patients allergic to propofol and oxycodone; Patients received opioids or sedatives 24 hours before surgery; Patients with chronic kidney disease; Drug or alcohol abuse; Patients with chronic pain; Patients with neurological diseases;

Design outcomes

Primary

Measure	Time frame
spontaneous movement;	—

Secondary

Measure	Time frame
HR;blood pressure;side effect;Pain score;	—

Countries

China

Contacts

Public ContactJuan Ni

Department of Anesthesiology West China Second University Hospital Sichuan University

nijuankiki@163.com18180609890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026